Lilly Eli & Co

Affiliations

  • Large Shareholder at Prevail Therapeutics Inc. (PRVL), 2021-01-22
  • Large Shareholder at Sigilon Therapeutics Inc. (SGTX), 2020-12-10
  • at Avidity Biosciences Inc. (RNA), 2020-06-16
  • Large Shareholder at Dermira Inc. (DERM), 2020-02-20
  • Large Shareholder at Elanco Animal Health Inc (ELAN), 2019-03-11
  • Other at Zymeworks Inc. (ZYME), 2019-02-06
  • Large Shareholder at Leap Therapeutics Inc. (LPTX), 2018-08-13
  • Large Shareholder at Colucid Pharmaceuticals Inc. (CLCD), 2017-03-01
  • Large Shareholder at Aeglea Biotherapeutics Inc. (AGLE), 2016-04-14
  • Large Shareholder at Zosano Pharma Corp (ZSAN), 2015-02-09
  • Other at Coherus Biosciences Inc. (CHRS), 2014-11-12
  • Large Shareholder at Cerulean Pharma Inc. (CERU), 2014-04-16
  • Large Shareholder at Receptos Inc. (RCPT), 2013-11-21
  • Large Shareholder at United Therapeutics Corp (UTHR), 2011-07-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SGTX $18.00 300,000 Large Shareholder 2,744,443 2020-12-08 Filing
AGLE $10.00 500,000 Large Shareholder 2,568,543 2016-04-12 Filing
CHRS $13.50 164,963 Other 3,042,019 2014-11-12 Filing
CERU $7.00 733,445 Large Shareholder 2,356,227 2014-04-15 Filing
RCPT $14.00 142,857 Large Shareholder 2,081,210 2013-05-14 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ZYME $16.00 250,000 Large Shareholder 2,898,647 2019-01-31 Filing
ZYME $14.00 700,000 Large Shareholder 3,148,647 2018-11-06 Filing
ZYME $16.36 2,027 Large Shareholder 3,848,647 2018-09-24 Filing
ZYME $14.56 6,870 Large Shareholder 3,850,674 2018-09-18 Filing
ZYME $14.58 6,865 Large Shareholder 3,857,544 2018-09-17 Filing